Drug intelligence / Profile preview

anti-c immunoglobulin

Development stage
Unknown
Modality
Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Anti-c immunoglobulin is a polyclonal antibody preparation used for the treatment of immune thrombocytopenic purpura (ITP), particularly in patients who are Rh-negative but c-positive. It consists of IgG antibodies directed against the c antigen of the Rh blood group system. When administered, these antibodies bind to the patient's red blood cells, which are then cleared by the spleen's macrophages. This clearance process saturates the Fc receptors on the macrophages, preventing them from destroying the patient's autoantibody-coated platelets, thereby raising the platelet count. This mechanism is known as Fc receptor blockade. While anti-D (Rho(D) immune globulin) is more commonly used for Rh-positive patients, anti-c provides a therapeutic option for Rh-negative individuals who possess the c antigen.

Other names
anti-c IgGRh(c) immune globulinanti-c antibodies
02

Targets

RHCE (Blood group Rh(CE) polypeptide)

Beyond the preview

Go deeper on anti-c immunoglobulin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on anti-c immunoglobulin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call